Search company, investor...

Compare Cellzome vs Heptares Therapeutics

Customers evaluate the quality of Cellzome's products using the following success metrics.

Overview

C

Cellzome is based in Germany

Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads, a technology for the screening and profiling of kinases in relevant cells and tissues.

Heptares Therapeutics is 17 yrs old and is based in United Kingdom.

Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization of GPCRs, a breakthrough allowing X-ray crystallography of conformationally-constrained receptors, thereby facilitating structure-based drug design at GPCRs that have been resistant to traditional methods of drug screening.

Country

Germany
United Kingdom

Demo Video

Demo not available because Cellzome has not claimed their profile.

Work for Cellzome? Show off your product.

Demo not available because Heptares Therapeutics has not claimed their profile.

Work for Heptares Therapeutics? Show off your product.

Leadership

Stelios B. Papadopoulos (Founder)

See all 5 people

Rob Cooke (Chief Technology Officer)

See all 5 people

Funding

Heptares Therapeutics last raised $5M on 5/18/2017.

Stage

Acquired
Corporate Minority

Latest Valuation

Investors

GSK, SV Health Investors

See all 5 investors

Teva Pharmaceuticals, Sosei Heptares

See all 5 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Cellzome has not claimed their profile.

Work for Cellzome? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Cellzome?

Claim your profile now.

Information not available because Heptares Therapeutics has not claimed their profile.

Work for Heptares Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Heptares Therapeutics?

Claim your profile now.